Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
29.05.24
/
50%
€46.00
Target price
29.05.25
€68.37
Performance (%)
33.70%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. The BUY prediction by The_Goldman_Sachs_Gr for Insmed Inc. saw massive gains of 33.70%. The_Goldman_Sachs_Gr has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -8.290% | -8.290% | 91.048% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten